Executive Functions May Predict Outcome in Deep Brain Stimulation of Anterior Nucleus of Thalamus for Treatment of Refractory Epilepsy

by Soila Järvenpää, Eija Rosti-Otajärvi, Sirpa Rainesalo, Linda Laukkanen, Kai Lehtimäki, Jukka Peltola, Jukka Peltola
Published 2018-05-01

Stimulation Induced Electrographic Seizures in Deep Brain Stimulation of the Anterior Nucleus of the Thalamus Do Not Preclude a Subsequent Favorable Treatment Response

by Tommi Nora, Hanna Heinonen, Mirja Tenhunen, Sirpa Rainesalo, Soila Järvenpää, Kai Lehtimäki, Kai Lehtimäki, Jukka Peltola, Jukka Peltola
Published 2018-02-01

Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs

by Kari-Matti Mäkelä, Aki Hietaharju, Antti Brander, Jukka Peltola
Published 2018-07-01

Improving the effectiveness of ANT DBS therapy for epilepsy with optimal current targeting

by Soila Järvenpää, Kai Lehtimäki, Sirpa Rainesalo, Timo Möttönen, Jukka Peltola
Published 2020-09-01

Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?

by Charlotte Lawthom, Jukka Peltola, Rob McMurray, Emma Dodd, Vicente Villanueva
Published 2018-09-01

A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy

by Pabitra Basnyat, Soila Järvenpää, Jani Raitanen, Marko Pesu, Kai Lehtimäki, Jukka Peltola
Published 2021-07-01

Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients

by Pabitra Basnyat, Marko Pesu, Mikael Söderqvist, Anna Grönholm, Suvi Liimatainen, Maria Peltola, Jani Raitanen, Jukka Peltola
Published 2020-06-01

Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage

by Heikki Kiiski, Jaakko Långsjö, Jyrki Tenhunen, Marika Ala-Peijari, Heini Huhtala, Mari Hämäläinen, Eeva Moilanen, Juha Öhman, Jukka Peltola
Published 2017-03-01